Search results
Results From The WOW.Com Content Network
Logo: SAMHSA's National Registry of Evidence-based Programs and Practices (NREPP), www.nrepp.samhsa.gov. In the behavioral health field, there is an ongoing need for researchers, developers, evaluators, and practitioners to share information about what works to improve outcomes among individuals coping with, or at risk for, mental disorders and substance abuse.
The Substance Abuse and Mental Health Services Administration (SAMHSA; pronounced / ˈ s æ m s ə /) is a branch of the U.S. Department of Health and Human Services.SAMHSA is charged with improving the quality and availability of treatment and rehabilitative services in order to reduce illness, death, disability, and the cost to society resulting from substance abuse and mental illnesses.
The journal was initially known as The Drug and Alcohol Professional (2001–2003) and edited by David B. Cooper. [5] In 2004, with Gary Hayes as editor, the journal was renamed Drugs and Alcohol Today, [6] a name that was kept until 2021. [7] In 2022, the name was changed to Drugs, Habits and Social Policy.
While previous reports by the Global Commission on Drug Policy showed how the potential harms of drugs for people and communities are exacerbated by repressive drug control policies at local, national and international levels, the Global Commission's 2017 report, "The World Drug Perception Problem - Countering Prejudices About People Who Use ...
Numerous social forces led to a move for deinstitutionalization; researchers generally give credit to six main factors: criticisms of public mental hospitals, incorporation of mind-altering drugs in treatment, support from President Kennedy for federal policy changes, shifts to community-based care, changes in public perception, and individual ...
The drug or other substance has a high potential for abuse. The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. Examples: heroin, LSD, marijuana, MDMA (ecstasy), methaqualone (quaalude). Schedule II
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
According to a detailed study of the most widely used outpatient drugs at five public hospitals, hospital costs for the previously discounted drugs increased, on average, by 32 percent, far in excess of the historical 5 to 9 percent annual increases in drug prices experienced by public hospitals.